Abstract | BACKGROUND: The use of phenobarbital for childhood epilepsy is controversial because of reported behavioural side-effects; however, whether this research can validly be extrapolated to developing countries is not clear. We undertook a randomised comparison of phenobarbital and phenytoin to assess the acceptability and efficacy of phenobarbital as monotherapy for childhood epilepsy in rural India. METHODS: Between August, 1995, and February, 1996, 109 unselected children aged 2-18 years with partial and generalised tonic-clonic epilepsy were identified by population screening. 15 families declined to take part. 94 children were randomly allocated treatment with phenobarbital (1.5 mg/kg daily for 2 weeks; maintenance dose 3.0 mg/kg daily; n = 47) or phenytoin (2.5 mg/kg daily then 5.0 mg/kg daily; n = 47). Children were followed up for 12 months. The primary outcome measure was the frequency of behavioural side-effects; behaviour was assessed by the Conners parent rating scale for children aged 6 years and older, and by the preschool behaviour screening questionnaire (BSQ) for those aged 2-5 years, at 12 months or at withdrawal from treatment. Analysis was by intention to treat. FINDINGS: The mean log-transformed scores on the behaviour rating scales did not differ significantly between the phenobarbital and phenytoin groups (Conners 2.64 [SD 0.71] vs 2.65 [0.89], p = 0.97; n = 32 in each group: BSQ 2.12 [1.31] vs 2.18 [1.02], p = 0.94; n = 4 vs 3). The odds ratio for behavioural problems ( phenobarbital vs phenytoin) was 0.51 (95% CI 0.16-1.59). There was no excess in parental reports of side-effects for phenobarbital. We found no difference in efficacy between the study drugs (adjusted hazard ratio for time to first seizure from randomisation 0.97 [0.28-3.30]). INTERPRETATION: This evidence supports the acceptability of phenobarbital as a first-line drug for childhood epilepsy in rural settings in developing countries.
|
Authors | D K Pal, T Das, G Chaudhury, A L Johnson, B G Neville |
Journal | Lancet (London, England)
(Lancet)
Vol. 351
Issue 9095
Pg. 19-23
(Jan 03 1998)
ISSN: 0140-6736 [Print] England |
PMID | 9433424
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anticonvulsants
- Phenytoin
- Phenobarbital
|
Topics |
- Adolescent
- Anticonvulsants
(adverse effects, therapeutic use)
- Child
- Child Behavior Disorders
(chemically induced, epidemiology)
- Child, Preschool
- Developing Countries
- Epilepsies, Partial
(drug therapy, epidemiology)
- Epilepsy, Generalized
(drug therapy, epidemiology)
- Feasibility Studies
- Female
- Follow-Up Studies
- Humans
- India
(epidemiology)
- Male
- Phenobarbital
(adverse effects, therapeutic use)
- Phenytoin
(adverse effects, therapeutic use)
- Proportional Hazards Models
- Rural Population
- Time Factors
- Treatment Outcome
|